Cancer Causes & Control

, Volume 23, Issue 12, pp 1911–1919 | Cite as

A history of allergies is associated with reduced risk of oral squamous cell carcinoma

  • Marni Stott-Miller
  • Chu Chen
  • David R. Doody
  • Joseph L. Carter
  • Denise A. Galloway
  • Margaret M. Madeleine
  • Stephen M. SchwartzEmail author
Original paper



A history of allergies is associated with a decreased risk of several types of cancers. Potential mechanisms include enhanced immune surveillance against tumor cells early in disease development and/or carcinogenic infectious agents. We tested whether allergies are inversely associated with oral squamous cell carcinoma (OSCC), accounting for factors that may modify the association, such as tumor site, stage, and HPV infection.


We estimated odds ratios (OR) and 95 % confidence intervals (CI) for the association between allergy history (including different types of allergies) and OSCC, adjusted for potential confounders, among 400 cases and 613 controls. Analyses were also stratified by site, stage, and measures of HPV infection.


We observed a weak inverse association between history of any allergy and OSCC (OR = 0.81, 95 % CI 0.61–1.08). This association was present only for allergies to airborne allergens (dust/pollen/mold) (OR = 0.67; 95 % CI 0.48–0.93). The inverse associations with airborne allergies were slightly stronger for oropharyngeal SCC (OR = 0.56; 95 % CI 0.35–0.90) than for oral cavity SCC (OR = 0.71; 95 % CI 0.49–1.05) and present only for later-stage cancers (OR = 0.42; 95 % CI 0.26–0.66) as opposed to earlier-stage cancers (OR = 0.98; 95 % CI 0.66–1.46). Inverse associations were not particularly present or stronger among HPV-16-seropositive individuals or for HPV DNA-positive OSCC.


There is an inverse association between history of allergies to dust, pollen, or mold and OSCC. Whether the inverse association involves heightened immune surveillance, increased immune response to HPV or other antigen, or other carcinogenic mechanism remains to be determined in more definitive studies.


Allergies Oral squamous cell carcinoma HPV HSV 



This work was supported by a fellowship (5T32DE007132-28) and research project grants (R01CA048896 and R01DE012609) from the United States NIH and institutional funds from the Fred Hutchinson Cancer Research Center.

Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Negri E, Bosetti C, La Vecchia C, Levi F, Tomei F, Franceschi S (1999) Allergy and other selected diseases and risk of colorectal cancer. Eur J Cancer 35(13):1838–1841PubMedCrossRefGoogle Scholar
  2. 2.
    Bosetti C, Talamini R, Franceschi S, Negri E, Giacosa A, La Vecchia C (2004) Allergy and the risk of selected digestive and laryngeal neoplasms. Eur J Cancer Prev 13(3):173–176PubMedCrossRefGoogle Scholar
  3. 3.
    Vena JE, Bona JR, Byers TE, Middleton E Jr, Swanson MK, Graham S (1985) Allergy-related diseases and cancer: an inverse association. Am J Epidemiol 122(1):66–74PubMedGoogle Scholar
  4. 4.
    Johnson LG, Schwartz SM, Malkki M, Du Q, Petersdorf EW, Galloway DA, Madeleine MM (2011) Risk of cervical cancer associated with allergies and polymorphisms in genes in the chromosome 5 cytokine cluster. Cancer Epidemiol Biomarkers Prev 20(1):199–207PubMedCrossRefGoogle Scholar
  5. 5.
    Dai Q, Zheng W, Ji BT, Shu XO, Jin F, Cheng HX, Gao YT (1997) Prior immunity-related medical conditions and oesophageal cancer risk: a population-based case-control study in Shanghai. Eur J Cancer Prev 6(2):152–157PubMedGoogle Scholar
  6. 6.
    Vesterinen E, Pukkala E, Timonen T, Aromaa A (1993) Cancer incidence among 78,000 asthmatic patients. Int J Epidemiol 22(6):976–982PubMedCrossRefGoogle Scholar
  7. 7.
    Gandini S, Lowenfels AB, Jaffee EM, Armstrong TD, Maisonneuve P (2005) Allergies and the risk of pancreatic cancer: a meta-analysis with review of epidemiology and biological mechanisms. Cancer Epidemiol Biomarkers Prev 14(8):1908–1916PubMedCrossRefGoogle Scholar
  8. 8.
    Holly EA, Eberle CA, Bracci PM (2003) Prior history of allergies and pancreatic cancer in the San Francisco Bay area. Am J Epidemiol 158(5):432–441PubMedCrossRefGoogle Scholar
  9. 9.
    Källén B, Gunnarskog J, Conradson TB (1993) Cancer risk in asthmatic subjects selected from hospital discharge registry. Eur Respir J 6(5):694–697PubMedGoogle Scholar
  10. 10.
    Severson RK, Davis S, Thomas DB, Stevens RG, Heuser L, Sever LE (1989) Acute myelocytic leukemia and prior allergies. J Clin Epidemiol 42(10):995–1001PubMedCrossRefGoogle Scholar
  11. 11.
    Wen W, Shu XO, Linet MS, Neglia JP, Potter JD, Trigg ME, Robison LL (2000) Allergic disorders and the risk of childhood acute lymphoblastic leukemia (United States). Cancer Causes Control 11(4):303–307PubMedCrossRefGoogle Scholar
  12. 12.
    Wiemels JL, Wiencke JK, Sison JD, Miike R, McMillan A, Wrensch M (2002) History of allergies among adults with glioma and controls. Int J Cancer 98(4):609–615PubMedCrossRefGoogle Scholar
  13. 13.
    Mills PK, Beeson WL, Fraser GE, Phillips RL (1992) Allergy and cancer: organ site-specific results from the Adventist Health Study. Am J Epidemiol 136(3):287–295PubMedGoogle Scholar
  14. 14.
    Osann KE (1991) Lung cancer in women: the importance of smoking, family history of cancer, and medical history of respiratory disease. Cancer Res 51(18):4893–4897PubMedGoogle Scholar
  15. 15.
    Santillan AA, Camargo CA Jr, Colditz GA (2003) A meta-analysis of asthma and risk of lung cancer (United States). Cancer Causes Control 14(4):327–334PubMedCrossRefGoogle Scholar
  16. 16.
    Burnet M (1957) Cancer: a biological approach. III. Viruses associated with neoplastic conditions. IV. Practical applications. Br Med J 1:841–847PubMedCrossRefGoogle Scholar
  17. 17.
    Mackay WD (1966) The incidence of allergic disorders and cancer. Br J Cancer 20:434–437PubMedCrossRefGoogle Scholar
  18. 18.
    Volkers N (1999) Wheezing, sneezing, and cancer risk—still an open door. J Natl Cancer Inst 91(22):1916–1918PubMedCrossRefGoogle Scholar
  19. 19.
    Eriksson NE, Holmén A, Högstedt B, Mikoczy Z, Hagmar L (1995) A prospective study of cancer incidence in a cohort examined for allergy. Allergy 50(9):718–722PubMedCrossRefGoogle Scholar
  20. 20.
    Swann JB, Smyth MJ (2007) Immune surveillance of tumors. J Clin Invest 117(5):1137–1146PubMedCrossRefGoogle Scholar
  21. 21.
    Profet M (1991) The function of allergy: immunological defense against toxins. Q Rev Biol 66(1):23–62PubMedCrossRefGoogle Scholar
  22. 22.
    Sherman PW, Holland E, Sherman JS (2008) Allergies: their role in cancer prevention. Q Rev Biol 83(4):339–362PubMedCrossRefGoogle Scholar
  23. 23.
    Turner MC, Chen Y, Krewski D, Ghadirian P, Thun MJ, Calle EE (2005) Cancer mortality among US men and women with asthma and hay fever. Am J Epidemiol 162(3):212–221PubMedCrossRefGoogle Scholar
  24. 24.
    Siemiatycki J, Krewski D, Shi Y, Goldberg MS, Nadon L, Lakhani R (2003) Controlling for potential confounding by occupational exposures. J Toxicol Environ Health A 66(16–19):1591–1603PubMedCrossRefGoogle Scholar
  25. 25.
    Michaud DS, Langevin SM, Eliot M, Nelson HH, McClean MD, Christensen BC, Marsit CJ, Kelsey KT (2012) Allergies and risk of head and neck cancer. Cancer Causes Control 23(8):1317–1322PubMedCrossRefGoogle Scholar
  26. 26.
    Maden C, Beckmann AM, Thomas DB, McKnight B, Sherman KJ, Ashley RL, Corey L, Daling JR (1992) Human papillomaviruses, herpes simplex viruses, and the risk of oral cancer in men. Am J Epidemiol 135(10):1093–1102PubMedGoogle Scholar
  27. 27.
    Schwartz SM, Daling JR, Doody DR, Wipf GC, Carter JJ, Madeleine MM, Mao EJ, Fitzgibbons ED, Huang S, Beckmann AM, McDougall JK, Galloway DA (1998) Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst 90(21):1626–1636PubMedCrossRefGoogle Scholar
  28. 28.
    Starr JR, Daling JR, Fitzgibbons ED, Madeleine MM, Ashley R, Galloway DA, Schwartz SM (2001) Serologic evidence of herpes simplex virus 1 infection and oropharyngeal cancer risk. Cancer Res 61(23):8459–8464PubMedGoogle Scholar
  29. 29.
    Wideroff L, Schiffman MH, Nonnenmacher B, Hubbert N, Kirnbauer R, Greer CE, Lowy D, Lorincz AT, Manos MM, Glass AG, Scott DR, Sherman ME et al (1995) Evaluation of seroreactivity to human papillomavirus type 16 virus-like particles in an incident case-control study of cervical neoplasia. J Infect Dis 172(6):1425–1430PubMedCrossRefGoogle Scholar
  30. 30.
    Carter JJ, Koutsky LA, Wipf GC, Christensen ND, Lee SK, Kuypers J, Kiviat N, Galloway DA (1996) The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women. J Infect Dis 174(5):927–936PubMedCrossRefGoogle Scholar
  31. 31.
    Merrill RM, Isakson RT, Beck RE (2007) The association between allergies and cancer: what is currently known? Ann Allergy Asthma Immunol 99(2):102–116 quiz 117–119, 150PubMedCrossRefGoogle Scholar
  32. 32.
    Turner MC, Chen Y, Krewski D, Ghadirian P (2006) An overview of the association between allergy and cancer. Int J Cancer 118(12):3124–3132PubMedCrossRefGoogle Scholar
  33. 33.
    Parker TM, Smith EM, Ritchie JM, Haugen TH, Vonka V, Turek LP, Hamsikova E (2006) Head and neck cancer associated with herpes simplex virus 1 and 2 and other risk factors. Oral Oncol 42(3):288–296PubMedCrossRefGoogle Scholar
  34. 34.
    Larsson PA, Edström S, Westin T, Nordkvist A, Hirsch JM, Vahlne A (1991) Reactivity against herpes simplex virus in patients with head and neck cancer. Int J Cancer 49(1):14–18PubMedCrossRefGoogle Scholar
  35. 35.
    Arbes SJ Jr, Gergen PJ, Elliott L, Zeldin DC (2005) Prevalences of positive skin test responses to 10 common allergens in the US population: results from the third National Health and Nutrition Examination Survey. J Allergy Clin Immunol 116(2):377–383PubMedCrossRefGoogle Scholar
  36. 36.
    Kreimer AR, Clifford GM, Boyle P, Franceschi S (2005) Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 14(2):467–475PubMedCrossRefGoogle Scholar
  37. 37.
    Snijders PJ, van den Brule AJ, Meijer CJ (2003) The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity. J Pathol 201(1):1–6PubMedCrossRefGoogle Scholar
  38. 38.
    Miller CS, White DK (1996) Human papillomavirus expression in oral mucosa, premalignant conditions, and squamous cell carcinoma: a retrospective review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 82(1):57–68PubMedCrossRefGoogle Scholar
  39. 39.
    Gravitt P, Viscidi R (2004) Chapter 5: Measurement of exposure to human papillomavirus. In: Rohan T, Shah K (eds) Cervical cancer: from etiology to prevention. Kluwer Academic Publishers, London, pp 119–141CrossRefGoogle Scholar
  40. 40.
    Herrero R, Castellsagué X, Pawlita M, Lissowska J, Kee F, Balaram P, Rajkumar T, Sridhar H, Rose B, Pintos J, Fernández L, Idris A et al (2003) Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 95(23):1772–1783PubMedCrossRefGoogle Scholar
  41. 41.
    Meschede W, Zumbach K, Braspenning J, Scheffner M, Benitez-Bribiesca L, Luande J, Gissmann L, Pawlita M (1998) Antibodies against early proteins of human papillomaviruses as diagnostic markers for invasive cervical cancer. J Clin Microbiol 36(2):475–480PubMedGoogle Scholar
  42. 42.
    Johansson SG, Bieber T, Dahl R et al (2004) Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 113(5):832–836PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2012

Authors and Affiliations

  • Marni Stott-Miller
    • 1
    • 2
  • Chu Chen
    • 1
    • 2
    • 3
  • David R. Doody
    • 1
  • Joseph L. Carter
    • 1
  • Denise A. Galloway
    • 1
  • Margaret M. Madeleine
    • 1
    • 2
  • Stephen M. Schwartz
    • 1
    • 2
    Email author
  1. 1.Fred Hutchinson Cancer Research CenterSeattleUSA
  2. 2.Department of EpidemiologyUniversity of WashingtonSeattleUSA
  3. 3.Department of Otolaryngology-Head and Neck SurgeryUniversity of WashingtonSeattleUSA

Personalised recommendations